Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TM | TSLA |
|---|---|---|
| Price | $187.21 | $379.79 |
| Change today | ▼ 1.65% | ▼ 0.09% |
| Market cap | $221.69B | $1.50T |
| Return, 3 months | +11.6% | +1.1% |
| Return, year to date | -11.2% | -15.5% |
| Return, 1 year | -2.6% | -14.2% |
| P/E (TTM) | 8.4 | 351.7 |
| P/B | 0.9 | 17.3 |
| P/E percentile vs own 5y | 22nd | 86th |
| Dividend yield | 3.05% | – |
| Revenue growth (YoY, latest qtr) | +10.4% | +25.5% |
| Net profit growth (YoY) | +77.9% | -5.2% |
| Gross margin | 16.8% | 18.9% |
| Operating margin | 7.1% | 4.6% |
| Net margin | 8.6% | 3.7% |
| Return on equity | 12.2% | 4.6% |
| Analyst target vs. price | – | +5.9% |
| Analyst buy share | – | 46% |
| RSI (14) | 48 | 60 |
| 30-day volatility | 20.5% | 44.2% |
| Max drawdown, 1 year | -31.9% | -39.1% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.